Contract developers are among the first customers for a new instrument for monitoring the freeze-drying of injectable drug products. That’s according to a team from the UK’s De Montfort ...

Pharmaceutical Technology® Group sat down with Thomas De Beer, co-founder and CEO of RheaVita, to talk about his presentation at INTERPHEX 2025, “GMP-ready Continuous & Controlled Pharmaceutical ...